Page last updated: 2024-09-05

sorafenib and zn(ii)-phthalocyanine

sorafenib has been researched along with zn(ii)-phthalocyanine in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (zn(ii)-phthalocyanine)	Trials (zn(ii)-phthalocyanine)	Recent Studies (post-2010) (zn(ii)-phthalocyanine)
6,520	730	5,251	445	2	290

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Deng, Y; Dong, L; Li, YH; Liu, J; Liu, TT; Shen, XZ; Yu, XN; Zhang, GC; Zhu, CF; Zhu, JM	1

Other Studies

1 other study(ies) available for sorafenib and zn(ii)-phthalocyanine

Article	Year
Sorafenib-Conjugated Zinc Phthalocyanine Based Nanocapsule for Trimodal Therapy in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model. ACS applied materials & interfaces, 2020, Apr-15, Volume: 12, Issue:15 Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Indoles; Isoindoles; Light; Liver Neoplasms; Male; Mice; Mice, Nude; Nanocapsules; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Phototherapy; Reactive Oxygen Species; Serum Albumin, Bovine; Sorafenib; Xenograft Model Antitumor Assays; Zinc Compounds	2020

Article

Year

Sorafenib-Conjugated Zinc Phthalocyanine Based Nanocapsule for Trimodal Therapy in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.

ACS applied materials & interfaces, 2020, Apr-15, Volume: 12, Issue:15

Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Indoles; Isoindoles; Light; Liver Neoplasms; Male; Mice; Mice, Nude; Nanocapsules; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Phototherapy; Reactive Oxygen Species; Serum Albumin, Bovine; Sorafenib; Xenograft Model Antitumor Assays; Zinc Compounds

2020